Literature DB >> 29220594

Modification of immunological features in human platelets during sepsis.

Valle-Jiménez Xareni Raque1,2, Sánchez-García Juan Carlos3, Revilla-Rodríguez Eduardo3, Baltierrez-Hoyos Rafael1, Romero-Tlalolini María de Los Ángeles1, Ramírez-Cosmes Adriana1, Torres-Aguilar Honorio1,4, Bustos-Arriaga José5, Aguilar-Ruiz Sergio Roberto1.   

Abstract

Sepsis is an organic dysfunction that puts at risk the life of patients suffering this disorder due to an exacerbated immunological response to the infection mediated by the host. Platelets have been largely researched on sepsis owing to its role in Disseminated Intracellular Coagulation (DIC) and because thrombocytopenia is an important clinical feature of these patients. Nevertheless, a great number of evidence shows that platelets have also an important role in immunological response since they have pattern recognition receptors, chemokine receptors and granules with stored soluble mediators. In this work, the immunological features of platelets in individuals with sepsis are described. The results show that platelets of these individuals have high levels of surfaces expression of TLR4, CD62P, CD32 and thrombin receptor 1 (PAR-1), these platelets have also greater capability to join Escherichia coli, and show a different profile of soluble mediators (IL-1β, CD40L and TNF-α). Platelets from patients with sepsis form aggregates with neutrophils in circulation, but are unable to induce the production of reactive oxygen species. This research describes important features of platelets to help the understanding of the immunological role of these cells in sepsis.

Entities:  

Keywords:  Inflammation; Sepsis; immunologic receptors; interaction with bacteria; platelets

Mesh:

Substances:

Year:  2017        PMID: 29220594     DOI: 10.1080/08820139.2017.1413113

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  2 in total

1.  Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.

Authors:  Dong Ling Tong; Karen E Kempsell; Tamas Szakmany; Graham Ball
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

2.  Research Advances in the Subtype of Sepsis-Associated Thrombocytopenia.

Authors:  Xinghui Wu; Yue Li; Huasheng Tong
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.